StockNews.com Begins Coverage on Cellectar Biosciences (NASDAQ:CLRB)
Investment analysts at StockNews.com initiated coverage on shares of Cellectar Biosciences (NASDAQ:CLRB – Get Free Report) in a report issued on Friday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. A number of other research firms have also recently weighed in on CLRB. LADENBURG THALM/SH SH assumed coverage on shares of Cellectar […]
Investment analysts at StockNews.com initiated coverage on shares of Cellectar Biosciences (NASDAQ:CLRB – Get Free Report) in a report issued on Friday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. A number of other research firms have also recently weighed in on CLRB. LADENBURG THALM/SH SH assumed coverage on shares of Cellectar […]
